Title

Epidural Dexamethasone Versus Betamethasone for Treatment of Lumbosacral Radiculalgia
Efficacy and Safety of Dexamethasone Versus Betamethasone Epidural Caudal Administration for Treatment of Lumbosacral Radiculalgia: Randomized Clinical Trial
  • Phase

    Phase 4
  • Study Type

    Interventional
  • Status

    Unknown status
  • Study Participants

    320
This study evaluate the administration of epidural betamethasone versus dexamethasone for pain reduction, consumption of analgesic and quality of life. Half of the patient will receive dexametasone and the other half betametasone.
Study Started
Jun 30
2016
Primary Completion
Jun 30
2018
Anticipated
Study Completion
Jun 30
2020
Anticipated
Last Update
Oct 25
2016
Estimate

Drug Betamethasone

Drug Dexamethasone

Group Betamethasone Experimental

One ampule containing 12 mg of betamethasone in a syringe of 10 ml

Group Dexamethasone Active Comparator

One ampule containing 4 mg of dexamethasone in a syringe os 10 ml

Criteria

Inclusion Criteria:

Unilateral leg pain secondary to lateral stenosis, disc protrusion or herniated disc.
Age between 18 and 80 years.
Moderate to severe pain (NVS>4).
Right proficient oral and written language.

Exclusion Criteria:

Patients with high intracranial pressure.
Patients with Multiple Sclerosis.
Patients with Guillain-Barré syndrome radiculopathy of vascular origin.
Patients with previous lumbar surgery.
Patients pregnant or lactating.
Patients with allergy or intolerance to any of the drugs used.
Patients with severe cognitive impairment.
Patients with intrathecal injectio radiculalgia.
Patients with poorly controlled major psychiatric pathology.
Patients with type I diabetes or poorly controlled type II diabetes (Hb1Ac>8.5).
Patients with glaucoma.
Patients with caudal equine syndrome.
Patients with pre-treatment with steroid injections/or local anesthetics.
Patients with central canal stenosis.
patients with chronic treatment with oral corticosteroids without stabilized pattern.
No Results Posted